The American Board of Internal Medicine and the American College of Cardiology have created the Collaborative Maintenance Pathway option for cardiologists to maintain their board certification.
Sleep apnea severity was associated with elevated pulmonary capillary wedge pressure in adults.
Statin adherence linked to significantly reduced risk for MACE.
Incidence of major cardiac implantable electronic device infections significantly lower with envelope.
Treatment with icosapent ethyl was associated with a substantial reduction in the risk of first, subsequent, and total ischemic events when compared with placebo in statin-treated patients with established cardiovascular (CV) disease or diabetes with other CV risk factors.
Dapagliflozin reduces MACE, CV death, and risk for heart failure hospitalization in patients with type 2 diabetes and prior MI.
Macitentan improved right ventricular function in patients with pulmonary arterial hypertension.
Veterans with elevated triglycerides showed significant increases in cardiovascular events despite having statin-controlled low-density lipoprotein cholesterol levels.
Age, gender, and etiology significantly influence prognosis together with the recently validated simplified PAH risk table but don’t significantly influence the response to PAH-specific treatment.
Real-world data indicate that lower risk of heart failure hospitalization and death associated with use of sodium-glucose cotransporter-2 inhibitors is consistent in patients with T2D with both reduced and preserved ejection fraction.
